Ingevity not immune to BASF's US antitrust claims, judge rules
MLex Summary: Counter to Ingevity's contentions, BASF did not waive its demand for a US jury trial such that the jury's findings as to "any factual issues relevant to the immunity...To view the full article, register now.
Already a subscriber? Click here to view full article